ロード中...
Cardioversion Safety − Are We Doing Enough?
There is a considerable periprocedural risk of thromboembolic events in atrial fibrillation patients undergoing cardioversion, and treatment with anticoagulants is therefore a hallmark of cardioversion safety. Based on retrospective subgroup analyses and prospective studies, non-vitamin K anticoagul...
保存先:
| 出版年: | Cardiology |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7677998/ https://ncbi.nlm.nih.gov/pubmed/32898849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509343 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|